Sclerostin influences body composition by regulating catabolic and anabolic metabolism in adipocytes

Soohyun P. Kim, Julie L. Frey, Zhu Li, Priyanka Kushwaha, Meredith L. Zoch, Ryan E. Tomlinson, Hao Da, Susan M Aja, Hye Lim Noh, Jason K. Kim, Mehboob Hussain, Daniel L.J. Thorek, Michael J Wolfgang, Ryan Riddle

Research output: Contribution to journalArticle

Abstract

Sclerostin has traditionally been thought of as a local inhibitor of bone acquisition that antagonizes the profound osteoanabolic capacity of activated Wnt/β-catenin signaling, but serum sclerostin levels in humans exhibit a correlation with impairments in several metabolic parameters. These data, together with the increased production of sclerostin in mouse models of type 2 diabetes, suggest an endocrine function. To determine whether sclerostin contributes to the coordination of whole-body metabolism, we examined body composition, glucose homeostasis, and fatty acid metabolism in Sost-/- mice as well as mice that overproduce sclerostin as a result of adeno-associated virus expression from the liver. Here, we show that in addition to dramatic increases in bone volume, Sost-/- mice exhibit a reduction in adipose tissue accumulation in association with increased insulin sensitivity. Sclerostin overproduction results in the opposite metabolic phenotype due to adipocyte hypertrophy. Additionally, Sost-/- mice and those administered a sclerostin-neutralizing antibody are resistant to obesogenic diet-induced disturbances in metabolism. This effect appears to be the result of sclerostin's effects on Wnt signaling and metabolism in white adipose tissue. Since adipocytes do not produce sclerostin, these findings suggest an unexplored endocrine function for sclerostin that facilitates communication between the skeleton and adipose tissue.

Original languageEnglish (US)
Pages (from-to)E11238-E11247
JournalProceedings of the National Academy of Sciences of the United States of America
Volume114
Issue number52
DOIs
StatePublished - Dec 26 2017

Fingerprint

Body Composition
Adipocytes
Adipose Tissue
Bone and Bones
Catenins
White Adipose Tissue
Dependovirus
Neutralizing Antibodies
Skeleton
Type 2 Diabetes Mellitus
Hypertrophy
Insulin Resistance
Homeostasis
Fatty Acids
Communication
Diet
Phenotype
Glucose
Liver
Serum

Keywords

  • Adipose
  • Bone
  • Metabolism
  • Sclerostin
  • Wnt

ASJC Scopus subject areas

  • General

Cite this

Sclerostin influences body composition by regulating catabolic and anabolic metabolism in adipocytes. / Kim, Soohyun P.; Frey, Julie L.; Li, Zhu; Kushwaha, Priyanka; Zoch, Meredith L.; Tomlinson, Ryan E.; Da, Hao; Aja, Susan M; Noh, Hye Lim; Kim, Jason K.; Hussain, Mehboob; Thorek, Daniel L.J.; Wolfgang, Michael J; Riddle, Ryan.

In: Proceedings of the National Academy of Sciences of the United States of America, Vol. 114, No. 52, 26.12.2017, p. E11238-E11247.

Research output: Contribution to journalArticle

Kim, Soohyun P. ; Frey, Julie L. ; Li, Zhu ; Kushwaha, Priyanka ; Zoch, Meredith L. ; Tomlinson, Ryan E. ; Da, Hao ; Aja, Susan M ; Noh, Hye Lim ; Kim, Jason K. ; Hussain, Mehboob ; Thorek, Daniel L.J. ; Wolfgang, Michael J ; Riddle, Ryan. / Sclerostin influences body composition by regulating catabolic and anabolic metabolism in adipocytes. In: Proceedings of the National Academy of Sciences of the United States of America. 2017 ; Vol. 114, No. 52. pp. E11238-E11247.
@article{99e21e9d83d94bafb03c310f6def4713,
title = "Sclerostin influences body composition by regulating catabolic and anabolic metabolism in adipocytes",
abstract = "Sclerostin has traditionally been thought of as a local inhibitor of bone acquisition that antagonizes the profound osteoanabolic capacity of activated Wnt/β-catenin signaling, but serum sclerostin levels in humans exhibit a correlation with impairments in several metabolic parameters. These data, together with the increased production of sclerostin in mouse models of type 2 diabetes, suggest an endocrine function. To determine whether sclerostin contributes to the coordination of whole-body metabolism, we examined body composition, glucose homeostasis, and fatty acid metabolism in Sost-/- mice as well as mice that overproduce sclerostin as a result of adeno-associated virus expression from the liver. Here, we show that in addition to dramatic increases in bone volume, Sost-/- mice exhibit a reduction in adipose tissue accumulation in association with increased insulin sensitivity. Sclerostin overproduction results in the opposite metabolic phenotype due to adipocyte hypertrophy. Additionally, Sost-/- mice and those administered a sclerostin-neutralizing antibody are resistant to obesogenic diet-induced disturbances in metabolism. This effect appears to be the result of sclerostin's effects on Wnt signaling and metabolism in white adipose tissue. Since adipocytes do not produce sclerostin, these findings suggest an unexplored endocrine function for sclerostin that facilitates communication between the skeleton and adipose tissue.",
keywords = "Adipose, Bone, Metabolism, Sclerostin, Wnt",
author = "Kim, {Soohyun P.} and Frey, {Julie L.} and Zhu Li and Priyanka Kushwaha and Zoch, {Meredith L.} and Tomlinson, {Ryan E.} and Hao Da and Aja, {Susan M} and Noh, {Hye Lim} and Kim, {Jason K.} and Mehboob Hussain and Thorek, {Daniel L.J.} and Wolfgang, {Michael J} and Ryan Riddle",
year = "2017",
month = "12",
day = "26",
doi = "10.1073/pnas.1707876115",
language = "English (US)",
volume = "114",
pages = "E11238--E11247",
journal = "Proceedings of the National Academy of Sciences of the United States of America",
issn = "0027-8424",
number = "52",

}

TY - JOUR

T1 - Sclerostin influences body composition by regulating catabolic and anabolic metabolism in adipocytes

AU - Kim, Soohyun P.

AU - Frey, Julie L.

AU - Li, Zhu

AU - Kushwaha, Priyanka

AU - Zoch, Meredith L.

AU - Tomlinson, Ryan E.

AU - Da, Hao

AU - Aja, Susan M

AU - Noh, Hye Lim

AU - Kim, Jason K.

AU - Hussain, Mehboob

AU - Thorek, Daniel L.J.

AU - Wolfgang, Michael J

AU - Riddle, Ryan

PY - 2017/12/26

Y1 - 2017/12/26

N2 - Sclerostin has traditionally been thought of as a local inhibitor of bone acquisition that antagonizes the profound osteoanabolic capacity of activated Wnt/β-catenin signaling, but serum sclerostin levels in humans exhibit a correlation with impairments in several metabolic parameters. These data, together with the increased production of sclerostin in mouse models of type 2 diabetes, suggest an endocrine function. To determine whether sclerostin contributes to the coordination of whole-body metabolism, we examined body composition, glucose homeostasis, and fatty acid metabolism in Sost-/- mice as well as mice that overproduce sclerostin as a result of adeno-associated virus expression from the liver. Here, we show that in addition to dramatic increases in bone volume, Sost-/- mice exhibit a reduction in adipose tissue accumulation in association with increased insulin sensitivity. Sclerostin overproduction results in the opposite metabolic phenotype due to adipocyte hypertrophy. Additionally, Sost-/- mice and those administered a sclerostin-neutralizing antibody are resistant to obesogenic diet-induced disturbances in metabolism. This effect appears to be the result of sclerostin's effects on Wnt signaling and metabolism in white adipose tissue. Since adipocytes do not produce sclerostin, these findings suggest an unexplored endocrine function for sclerostin that facilitates communication between the skeleton and adipose tissue.

AB - Sclerostin has traditionally been thought of as a local inhibitor of bone acquisition that antagonizes the profound osteoanabolic capacity of activated Wnt/β-catenin signaling, but serum sclerostin levels in humans exhibit a correlation with impairments in several metabolic parameters. These data, together with the increased production of sclerostin in mouse models of type 2 diabetes, suggest an endocrine function. To determine whether sclerostin contributes to the coordination of whole-body metabolism, we examined body composition, glucose homeostasis, and fatty acid metabolism in Sost-/- mice as well as mice that overproduce sclerostin as a result of adeno-associated virus expression from the liver. Here, we show that in addition to dramatic increases in bone volume, Sost-/- mice exhibit a reduction in adipose tissue accumulation in association with increased insulin sensitivity. Sclerostin overproduction results in the opposite metabolic phenotype due to adipocyte hypertrophy. Additionally, Sost-/- mice and those administered a sclerostin-neutralizing antibody are resistant to obesogenic diet-induced disturbances in metabolism. This effect appears to be the result of sclerostin's effects on Wnt signaling and metabolism in white adipose tissue. Since adipocytes do not produce sclerostin, these findings suggest an unexplored endocrine function for sclerostin that facilitates communication between the skeleton and adipose tissue.

KW - Adipose

KW - Bone

KW - Metabolism

KW - Sclerostin

KW - Wnt

UR - http://www.scopus.com/inward/record.url?scp=85039700422&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85039700422&partnerID=8YFLogxK

U2 - 10.1073/pnas.1707876115

DO - 10.1073/pnas.1707876115

M3 - Article

C2 - 29229807

AN - SCOPUS:85039700422

VL - 114

SP - E11238-E11247

JO - Proceedings of the National Academy of Sciences of the United States of America

JF - Proceedings of the National Academy of Sciences of the United States of America

SN - 0027-8424

IS - 52

ER -